SCHEMBL7746351

SCHEMBL7746351

O=C(O)c1c(O)c(=O)n(Cc2nc3ccccc3n2CCCCF)c2ccccc12

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FEN1 P39748 4/20 0.44
RECQL P46063 1/20 0.42
KMT2A Q03164 3/20 0.42
MEN1 O00255 2/20 0.42
ALDH1A1 P00352 2/20 0.42
CYP2C9 P11712 2/20 0.42
CYP2C19 P33261 2/20 0.42
CYP3A4 P08684 2/20 0.42
MAPT P10636 1/20 0.42
HTT P42858 1/20 0.42
TP53 P04637 1/20 0.41
ERCC5 P28715 2/20 0.41
SMN1; SMN2 Q16637 3/20 0.41
HSD17B10 Q99714 1/20 0.41
KDM4E B2RXH2 2/20 0.41
LMNA P02545 1/20 0.41
POLB P06746 1/20 0.41
CYP1A2 P05177 1/20 0.41
GLA P06280 1/20 0.41
CYP2D6 P10635 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7741914 0.87 ALDH1A1 (0.54) RECQLKMT2AMEN1ALDH1A1MAPT
SCHEMBL7746367 0.78 ALDH1A1 (0.48) RECQLKMT2AMEN1ALDH1A1MAPT
SCHEMBL7745691 0.76 SMN1; SMN2 (0.47) RECQLKMT2AMEN1ALDH1A1CYP2C9
SCHEMBL7745921 0.74 MEN1 (0.41) RECQLKMT2AMEN1ALDH1A1CYP2C9
SCHEMBL7746911 0.74 MEN1 (0.45) RECQLKMT2AMEN1ALDH1A1CYP2C9
SCHEMBL7741901 0.74 POLB (0.44) RECQLKMT2AMEN1CYP3A4MAPT
SCHEMBL7745852 0.73 CYP3A4 (0.59) RECQLKMT2AMEN1ALDH1A1CYP3A4
SCHEMBL7437388 0.73 ALDH1A1 (0.66) KMT2AMEN1ALDH1A1MAPTHTT
SCHEMBL7745935 0.72 MEN1 (0.39) RECQLKMT2AMEN1ALDH1A1CYP2C9
SCHEMBL7746317 0.72 MEN1 (0.43) RECQLKMT2AMEN1ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6774134-B2 FOR THERAPY OF RESPIRATORY SYNCYTIAL VIRUS INFECTION BRISTOL-MYERS SQUIBB COMPANY 2004-08-10 US disclosed
US-6774134-B2 FOR THERAPY OF RESPIRATORY SYNCYTIAL VIRUS INFECTION BRISTOL-MYERS SQUIBB COMPANY 2004-08-10 US disclosed